文献速递脑血管病外科

使用Woven EndoBridge技术治疗109例脑动脉瘤的安全性结果:英国初步结果

Safety results from the treatment of 109 cerebral aneurysms using the Woven EndoBridge technique: preliminary results in the United Kingdom.
PubMed 文献 · J Neurosurg · 2017-02-03

该研究通过英国14中心全国数据库分析109例患者(112次手术)使用WEB装置的安全性与临床结局,装置成功部署在109例患者中的103例(94.5%)和112次手术中的104次(92.9%),36.7%患者记录不良事件,15.6%事件可能与WEB装置相关,出院死亡率0%,>3个月随访死亡率5%(5/100)。作者认为WEB装置临床使用安全,血栓栓塞并发症风险应通过适当抗凝和正确选择装置尺寸最小化。

要点

  • 装置成功部署在109例患者中的103例(94.5%)和112次手术中的104次(92.9%)。
  • 36.7%(40/109)患者记录不良事件,15.6%(17/109)事件可能与WEB装置相关。
  • 出院死亡率0%,>3个月随访死亡率5%(5/100),出院病残率1.8%(2/109),>3个月随访病残率6%(6/100)。

核心结论

  • 英国数据显示WEB装置临床使用安全,血栓栓塞并发症风险应通过适当抗凝和正确选择装置尺寸最小化,抗凝方案有待进一步评估和标准化。

研究设计与样本

  • 建立覆盖英国14个中心的全国密码保护数据库,收集匿名信息,分析初始109例患者(112次手术)的并发症和临床结局,独立根因分析将并发症分类,改良Rankin量表(mRS)作为临床结局指标。

主要发现

  • 109例患者中103例(94.5%)成功部署WEB装置,112次手术中104次(92.9%)成功部署。
  • 36.7%(40/109)患者记录不良事件,15.6%(17/109)事件可能与WEB装置相关,其中2例有症状。
  • 血栓栓塞最常见,影响15.6%(17/109)患者,其中6.4%(7/109)有症状。
  • 出院死亡率0%,>3个月随访死亡率5%(5/100);出院病残率1.8%(2/109),>3个月随访病残率6%(6/100)。
  • 11例(10.1%)患者有持续临床后遗症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE The Woven Endobridge (WEB) device has been in clinical use for the treatment of brain aneurysms for the past 4 years. Observational studies to assess clinical outcome and related complications have been published. Clear evidence is required to better understand the safety profile of the WEB device. The authors here present a multicenter series that provides a detailed safety analysis focused on patient selection, procedural events, and technical issues of treated patients throughout the United Kingdom (UK). METHODS A nationwide password-protected database was set up to collect anonymous information across the UK (14 centers). Complications and clinical outcome were analyzed for the initial 109 patients (112 procedures). An independent root cause analysis classified the complications into groups (procedural, disease, device, ancillary device, and other). The modified Rankin Scale (mRS) was used as a marker of clinical outcome. RESULTS Each of the 109 patients had 1 aneurysm suitable for WEB treatment (109 aneurysms). Three patients had 2 procedures, making a total of 112 procedures performed. Eight procedures were abandoned because of access issues; 2 patients went on to have a successful procedure. All 109 patients had a preprocedure and discharge mRS scores recorded. One hundred patients had a recorded mRS score from a > 3-month follow-up. Deployment of the WEB device was successful in 103 (94.5%) of 109 patients and 104 (92.9%) of 112 procedures. One patient had 2 successful WEB procedures on separate occasions. Patients without a successfully implanted WEB device were included in the analysis. Selection analysis showed that the average patient age was 56.5 years among 34 men and 75 women. The percentage of incidental aneurysms was 58.7%, acute 16.5%, symptomatic 18.3%, and recurrent 6.4%. Further results analysis showed that 40 (36.7%) of 109 patients had recorded adverse events, including those unrelated to the WEB device. Events that could be related to the WEB device numbered 17 (15.6%) among the 109 patients. Two patients with device-related complications were symptomatic. Overall, 11 patients (10.1%) had persistent clinical sequelae. Thromboembolism was the most prevalent event, affecting 15.6% of the patients (17 of 109), and 6.4% of the patients (7 of 109) with a thromboembolism were symptomatic. Overall mortality before discharge was 0% and at the > 3-month follow-up was 5% (5 of 100 patients). Morbidity was defined as an mRS score increase to > 2. Overall morbidity at discharge was 1.8% (2 of 109) and at the > 3-month follow-up was 6% (6 of 100). No device-related morbidity or mortality was associated with this group. CONCLUSIONS The UK data show that the WEB device is safe for clinical use. Thromboembolic complication adds a risk that should be minimized with appropriate anticoagulation and correct sizing of the device. There is scope for further evaluation and standardization of an anticoagulation regimen for the WEB device.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lawson A, Molyneux A, Sellar R, et al. Safety results from the treatment of 109 cerebral aneurysms using the Woven EndoBridge technique: preliminary results in the United Kingdom. J Neurosurg. 2017. PMID: 28156251. doi:10.3171/2016.9.JNS152849

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。